| RS2141658932 |
OTOA
|
Health Risk |
Pathogenic |
Hearing loss, autosomal recessive |
| RS2141664466 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS2141665094 |
MEFV
|
Health Risk |
Likely pathogenic |
— |
| RS2141675686 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2141676232 |
UMOD
|
Health Risk |
Pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS2141676533 |
UMOD
|
Health Risk |
Pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS2141676543 |
UMOD
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS2141676609 |
UMOD
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS2141676806 |
UMOD
|
Health Risk |
Pathogenic |
— |
| RS2141676976 |
UMOD
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS2141688617 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2141693746 |
CLN3
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141693825 |
LRRK1
|
Health Risk |
Pathogenic |
— |
| RS2141695316 |
ABCA3
|
Health Risk |
Pathogenic |
— |
| RS2141696548 |
ABCA3
|
Health Risk |
Pathogenic |
Interstitial lung disease due to ABCA3 deficiency, Interstitial lung disease due to ABCA3 deficiency |
| RS2141698833 |
FBXO22
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Tayoun-Maawali syndrome |
| RS2141700836 |
OTOA
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 7, Autosomal recessive nonsyndromic hearing loss 22 |
| RS2141702839 |
CLN3
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141703433 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141703722 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141704162 |
CLN3
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141705504 |
ABCA3
|
Health Risk |
Pathogenic |
— |
| RS2141707084 |
CLN3
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141712336 |
CLN3
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141712529 |
CLN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 |
| RS2141714500 |
CLN3
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141714554 |
CLN3
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis 3 |
| RS2141715669 |
ABCA3
|
Health Risk |
Pathogenic |
Interstitial lung disease due to ABCA3 deficiency, Interstitial lung disease due to ABCA3 deficiency |
| RS2141716542 |
OTOA
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 22, Autosomal recessive nonsyndromic hearing loss 22 |
| RS2141719739 |
KNL1
|
Health Risk |
Pathogenic |
Microcephaly 4, primary |
| RS2141720777 |
KNL1
|
Health Risk |
Pathogenic |
— |
| RS2141721054 |
KNL1
|
Health Risk |
Likely pathogenic |
Microcephaly 4, primary |
| RS2141721909 |
CLN3
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141722729 |
CLN3
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141723087 |
OTOA
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 22, Autosomal recessive nonsyndromic hearing loss 22 |
| RS2141725707 |
TCF12
|
Health Risk |
Pathogenic |
TCF12-related craniosynostosis, TCF12-related craniosynostosis |
| RS2141745830 |
CHD2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2141746246 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141755356 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141755359 |
CHD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy 94, Inborn genetic diseases |
| RS2141771878 |
TBC1D2B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with seizures and gingival overgrowth, Neurodevelopmental disorder with seizures and gingival overgrowth |
| RS2141773306 |
KNL1
|
Health Risk |
Likely pathogenic |
— |
| RS2141773765 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2141773831 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2141773848 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2141773876 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2141774101 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2141774162 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2141774639 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2141774796 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2141778479 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141785016 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141785162 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141787520 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141787589 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141787733 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141790977 |
CHD2
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2141791104 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141800223 |
IFT140
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 80, Cystic renal disease |
| RS2141802487 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141802547 |
CHD2
|
Health Risk |
Pathogenic |
— |
| RS2141802578 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141805160 |
TBC1D2B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with seizures and gingival overgrowth, Neurodevelopmental disorder with seizures and gingival overgrowth |
| RS2141805189 |
TBC1D2B
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with seizures and gingival overgrowth, Neurodevelopmental disorder with seizures and gingival overgrowth |
| RS2141806882 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive sclerosing poliodystrophy, Sensory ataxic neuropathy |
| RS2141811616 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141814810 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2141814886 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141815273 |
POLG
|
Health Risk |
Pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS2141815476 |
POLG
|
Health Risk |
Likely pathogenic |
— |
| RS2141816511 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141816525 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141816539 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141816540 |
IFT140
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 80, Saldino-Mainzer syndrome |
| RS2141816549 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141816557 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141830701 |
CHD2
|
Health Risk |
Pathogenic |
— |
| RS2141836224 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141837067 |
WDR73
|
Health Risk |
Pathogenic/Likely pathogenic |
Galloway-Mowat syndrome 1, Galloway-Mowat syndrome 1 |
| RS2141839134 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141839141 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Intellectual disability |
| RS2141843174 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141843225 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141843235 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141844210 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141844216 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141844219 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141844243 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141844251 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141844278 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141846356 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141846587 |
WDR73
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2141850583 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141850628 |
CHD2
|
Health Risk |
Likely pathogenic |
— |
| RS2141850669 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141851983 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141852009 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141852057 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141861645 |
CHD2
|
Health Risk |
Likely pathogenic |
— |
| RS2141861661 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |